We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0Q3A market cap is 498.17B. The company's latest EPS is HUF 36.8509 and P/E is 19.27.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
HUF (HUF) | HUF (HUF) | HUF (HUF) | HUF (HUF) | HUF (HUF) | |
Total Revenue | 293.58B | 226.07B | 301.44B | 521.34B | 667.42B |
Operating Income | -40.46B | -783.18M | 16.69B | 37.87B | 50.08B |
Net Income | -27.13B | -6.52B | 31.75B | 12.32B | 25.86B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
HUF (HUF) | HUF (HUF) | HUF (HUF) | HUF (HUF) | HUF (HUF) | |
Total Assets | 646.21B | 560.08B | 889.52B | 1.04T | 1.07T |
Total Liabilities | 358.66B | 332.46B | 575.05B | 699.32B | 716.87B |
Total Equity | 287.56B | 227.62B | 314.46B | 343.26B | 355.78B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
HUF (HUF) | HUF (HUF) | HUF (HUF) | HUF (HUF) | HUF (HUF) | |
Operating | -20.27B | 50.3B | 32.45B | 101.39B | 86.78B |
Investing | -68.11B | -11.15B | -104.5B | -52.3B | -28.82B |
Financing | 76.89B | 10.08B | 77.89B | -14.65B | 15.77B |
Market Cap | 498.17B |
Price to Earnings Ratio | 19.27 |
Price to Sales Ratio | 0.75 |
Price to Cash Ratio | 2.01 |
Price to Book Ratio | 1.4 |
Dividend Yield | - |
Shares Outstanding | 701.65M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | 0.00% |
52 Week High | 710.00 |
52 Week Low | 710.00 |
Spread (Intraday) | 0 (0%) |
Company Name | Opimus Group Nyrt |
Address |
andrassy ut 59 budapest H-1062 |
Website | https://www.opusglobal.hu |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions